From Salk Institute Breakthrough to Bedside: Vitamin D Analog Disarms Pancreatic Cancer’s Defenses in Clinical Trial
In a groundbreaking clinical investigation, researchers at the Dana-Farber Cancer Institute have tested a novel therapeutic concept originating from the ...
